Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...
For 17 years, Ken Jones fought fires in San Francisco. Now, he is fighting cancer -- and the insurance company that insures ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Retired SFFD firefighter battling metastatic lung cancer is denied coverage by city-provided Blue Shield Medicare Advantage ...
IMAGES BELOW] 11-month sustained complete resolution of lung metastasis observed in Bria-OTS Phase 1/2a metastatic breast ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...
Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” said Rebecca Siegel, ...
New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the ...